Close
Nordic 9Nordic 9

Rock Springs Capital (investor - Venture Capital)

United States rockspringscapital.com
See something wrong or missing? Let us know
Offices:Baltimore
Average round investment:131.67M USD
Average number per year:3.0
Distribution: 2023 (3)
Portfolio companies: United Kingdom Apollo TherapeuticsDenmark Hemab
Mostly invests in: United Kingdom United Kingdom (2) Biotech (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Rock Springs Capital

Name Criteria
United States Viking Global Investors
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United States Iconiq Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Israel Canaan Partners
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Pharma, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Denmark
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
Denmark Axcel
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Pharma, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United States TPG
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States Bill & Melinda Gates Foundation Trust
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Singapore ABC World
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Qatar Qatar Investment Authority
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom Intermediate Capital Group
81%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Pharma, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Denmark ATP
81%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Top